| - GRCh37:
- Chr16:86601468-86601470
- GRCh38:
- Chr16:86567862-86567864
| FOXC2 | K177del | Distichiasis-lymphedema syndrome | Uncertain significance (Feb 22, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86602206
- GRCh38:
- Chr16:86568600
| FOXC2 | A422V | Distichiasis-lymphedema syndrome | Uncertain significance (Apr 8, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86602162
- GRCh38:
- Chr16:86568556
| FOXC2 | Q407fs | Distichiasis-lymphedema syndrome | Likely pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86601827-86601828
- GRCh38:
- Chr16:86568221-86568222
| FOXC2 | | Distichiasis-lymphedema syndrome, not provided | Uncertain significance (Dec 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:86601239
- GRCh38:
- Chr16:86567633
| FOXC2, FOXC2-AS1 | Q100* | Distichiasis-lymphedema syndrome | Pathogenic (Jul 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86602097-86602117
- GRCh38:
- Chr16:86568491-86568511
| FOXC2 | | Distichiasis-lymphedema syndrome, not provided | Uncertain significance (Mar 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:86601911
- GRCh38:
- Chr16:86568305
| FOXC2 | A325fs | Distichiasis-lymphedema syndrome | Pathogenic (Jul 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86601723
- GRCh38:
- Chr16:86568117
| FOXC2 | A261D | Distichiasis-lymphedema syndrome | Uncertain significance (Oct 7, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86601701
- GRCh38:
- Chr16:86568095
| FOXC2 | G254R | Distichiasis-lymphedema syndrome | Uncertain significance (Aug 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86601650-86601651
- GRCh38:
- Chr16:86568044-86568045
| FOXC2 | Q238fs | Distichiasis-lymphedema syndrome | Pathogenic (Nov 20, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86601502-86601512
- GRCh38:
- Chr16:86567896-86567906
| FOXC2 | P188fs | Distichiasis-lymphedema syndrome | Pathogenic (Nov 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86601288
- GRCh38:
- Chr16:86567682
| FOXC2, FOXC2-AS1 | W116* | Distichiasis-lymphedema syndrome | Likely pathogenic (Jun 20, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86602305
- GRCh38:
- Chr16:86568699
| FOXC2 | N455S | not provided, Distichiasis-lymphedema syndrome | Likely benign (Jul 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:86601546
- GRCh38:
- Chr16:86567940
| FOXC2 | D202A | not provided, Distichiasis-lymphedema syndrome | Likely benign (Sep 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:86601880
- GRCh38:
- Chr16:86568274
| FOXC2 | Y313* | Distichiasis-lymphedema syndrome | Likely pathogenic (Dec 21, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86600942-86602447
- GRCh38:
- Chr16:86567336-86568841
| FOXC2, FOXC2-AS1 | | Distichiasis-lymphedema syndrome | Likely pathogenic (Apr 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86602199
- GRCh38:
- Chr16:86568593
| FOXC2 | Q420* | Distichiasis-lymphedema syndrome | Pathogenic (Jan 2, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:86602146
- GRCh38:
- Chr16:86568540
| FOXC2 | P402L | Distichiasis-lymphedema syndrome | Pathogenic (Jan 2, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:86601063
- GRCh38:
- Chr16:86567457
| FOXC2, FOXC2-AS1 | Y41F | Distichiasis-lymphedema syndrome | Pathogenic (Jan 2, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:86601302
- GRCh38:
- Chr16:86567696
| FOXC2, FOXC2-AS1 | R121C | not provided, Distichiasis-lymphedema syndrome, Inborn genetic diseases
| Pathogenic/Likely pathogenic (May 26, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:86602272
- GRCh38:
- Chr16:86568666
| FOXC2 | Q444R | not provided, Distichiasis-lymphedema syndrome | Conflicting interpretations of pathogenicity (Sep 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:86601303
- GRCh38:
- Chr16:86567697
| FOXC2, FOXC2-AS1 | R121H | Distichiasis-lymphedema syndrome | Pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86601315
- GRCh38:
- Chr16:86567709
| FOXC2, FOXC2-AS1 | S125L | Distichiasis-lymphedema syndrome | Pathogenic (Sep 15, 2005) | no assertion criteria provided |
| - GRCh37:
- Chr16:86601543-86601622
- GRCh38:
- Chr16:86567937-86568016
| FOXC2 | | Distichiasis-lymphedema syndrome | Pathogenic (Nov 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr16:86601855-86601862
- GRCh38:
- Chr16:86568249-86568256
| FOXC2 | Y305fs | Distichiasis-lymphedema syndrome | Pathogenic (Nov 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:86601446
- GRCh38:
- Chr16:86567840
| FOXC2 | K170fs | Distichiasis-lymphedema syndrome | Pathogenic (May 15, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr16:86601527-86601528
- GRCh38:
- Chr16:86567921-86567922
| FOXC2 | T197fs | Distichiasis-lymphedema syndrome | Pathogenic (Mar 1, 2008) | no assertion criteria provided |
| - GRCh37:
- Chr16:86601140-86601141
- GRCh38:
- Chr16:86567534-86567535
| FOXC2, FOXC2-AS1 | K68fs | Distichiasis-lymphedema syndrome | Pathogenic (Jun 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr16:86601149-86601150
- GRCh38:
- Chr16:86567543-86567544
| FOXC2, FOXC2-AS1 | V71fs | Distichiasis-lymphedema syndrome | Pathogenic (Jun 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr16:86602272
- GRCh38:
- Chr16:86568666
| FOXC2 | Q444fs | Distichiasis-lymphedema syndrome | Pathogenic (Jun 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr16:86601230-86601240
- GRCh38:
- Chr16:86567624-86567634
| FOXC2, FOXC2-AS1 | G97fs | Distichiasis-lymphedema syndrome | Pathogenic (Jun 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr16:86602029-86602030
- GRCh38:
- Chr16:86568423-86568424
| FOXC2 | P365fs | Distichiasis-lymphedema syndrome | Pathogenic (Dec 1, 2000) | no assertion criteria provided |
| - GRCh37:
- Chr16:86601238
- GRCh38:
- Chr16:86567632
| FOXC2, FOXC2-AS1 | Y99* | Distichiasis-lymphedema syndrome | Likely pathogenic (Mar 22, 2022) | criteria provided, single submitter |